AKEBIA THREAPEUTICS INC
AKBA·00972D105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AKBA (AKEBIA THREAPEUTICS INC) is held by 100 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($22.8M), VANGUARD CAPITAL MANAGEMENT LLC ($12.9M), AQR CAPITAL MANAGEMENT LLC ($10.4M). Net institutional sentiment: Mixed.
100
Holders
(9 Elite)
$110.7M
Total Value
64% (106)
Consensus
68 buying - 38 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 10, 2026 · Activists May 12, 2026 · Congress none
InsiderBPButler John P.Exercise 350K shAug 6, 2026
InsiderOEOstrowski ErikSell $62KJun 29, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 114
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer